Radcliffe Capital Management, L.P. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 66 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$7,790,647
+1.8%
718,701
-0.0%
0.97%
+48.6%
Q2 2023$7,654,656
+2.4%
718,747
+0.4%
0.65%
+39.6%
Q1 2023$7,474,403
+31.2%
715,939
+28.9%
0.47%
+159.4%
Q4 2022$5,697,942
+41.5%
555,355
+38.4%
0.18%
+85.6%
Q3 2022$4,027,000
+0.2%
401,2790.0%0.10%
+5.4%
Q2 2022$4,019,000
+1.7%
401,279
+0.3%
0.09%
+2.2%
Q1 2022$3,953,000400,1000.09%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 66,607$6851.08%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,482,836$15,2440.42%
MMCAP International Inc. SPC 400,000$4,088,0000.42%
CANTOR FITZGERALD, L. P. 1,422,204$14,5570.31%
KIM, LLC 500,000$5,1400.28%
Spartan Fund Management Inc. 74,485$7630.28%
Saba Capital Management, L.P. 1,791,845$18,384,3300.25%
Atalaya Capital Management LP 125,000$1,285,0000.23%
Radcliffe Capital Management, L.P. 555,355$5,697,9420.18%
Exos TFP Holdings LLC 62,500$638,7500.18%
View complete list of BIOPLUS ACQUISITION CORP shareholders